AF
DRTS icon

Aquamarine Financial’s Alpha Tau Medical DRTS Stock Holding History

Aquamarine Financial’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.08M Hold
721,501
– – 0.5% 11
2026
Q1 		$5.1M Buy
+721,501
New +$5.09M 0.37% 12

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Aquamarine Financial's DRTS Position: Q2 2026 in Review

Aquamarine Financial held its Alpha Tau Medical (DRTS) position steady in Q2 2026 at 721,501 shares worth $9.08M. The position accounts for 0.5% of the portfolio, ranked #11.

Aquamarine Financial first reported a position in DRTS in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Aquamarine Financial held 721,501 shares of Alpha Tau Medical worth $9.08M as of Q2 2026.
  • Aquamarine Financial left its Alpha Tau Medical share count unchanged in Q2 2026.
  • Alpha Tau Medical made up 0.5% of Aquamarine Financial's portfolio in Q2 2026, its #11 holding.
  • Aquamarine Financial first reported a position in Alpha Tau Medical in Q1 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Aquamarine Financial's 13F filing for Q2 2026, filed 12 Aug 2026.